If diabetes runs in your family, circumstances may have required you to learn about the challenges of Type 2 diabetes and the medications, including Actos (pioglitazone), necessary to confront this pernicious disease. Sadly, while Actos may offer temporary relief, long-term Actos patients should be aware of the risk of this drug.
The U.S. Food and Drug Administration (FDA) has stated emphatically that pioglitazone treatments lasting longer than twelve months have a significantly increased likelihood of causing harm to the patient. In fact, the risk of developing bladder cancer could increase by as much as 40 percent as a result of extended pioglitazone treatments. For this reason, French and German government health advisors have strongly cautioned against Actos.
Want to find out what Actos may mean for your family? Your family member’s rights may have been impacted by pioglitazone treatments. To learn more, contact the professionals at Fears Nachawati today. With years of experience, we know how to help you. For a free consultation, call 1.866.545.8364 or email mn@fnlawfirm.com.